Description
A-RAB-20, with Rabeprazole Sodium as its active component, is a proton pump inhibitor (PPI) that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase in the gastric parietal cell. By acting specifically on the proton pump, Rabeprazole blocks the final step in acid production, thus reducing gastric acidity. This injectable form is often reserved for cases where oral administration is not feasible, such as with severe gastric ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome. It is indicated for intravenous use only and is provided in a lyophilized form to ensure stability of the medication until it is reconstituted for injection. The packaging indicates that this product is intended for use under the guidance and prescription of a healthcare professional.
Reviews
There are no reviews yet.